Literature DB >> 25759546

Radical gastrectomy with hepatoarterial catheter implantation for late-stage gastric cancer.

Guo-Liang Yao1, Yong-Gang Fan1, Jing-Ming Zhai1, Bao-Sai Lu1, Kai-Long Liu1.   

Abstract

AIM: To determine the optimal type of surgery for late-stage gastric cancer with hepatic metastases.
METHODS: We retrospectively analyzed 49 gastrectomies for late-stage gastric cancer conducted in the First Hospital Affiliated to Henan University of Science and Technology between September 2003 and September 2010. All gastrectomy operations were divided into two groups: radical resection (gastrectomy and simultaneous resection of hepatic metastases, n = 31), and palliative resection (gastrectomy without hepatic resection, n = 18). All 49 patients had chemotherapy catheter implantation in the hepatic artery via the gastroduodenal artery. Postoperative complications and cumulative survival rates of the two groups were compared and analyzed.
RESULTS: There was no significant difference in the number of perioperative complications between the radical and palliative resection groups (6 and 3 cases, respectively, P > 0.05). The incidence of long-term complications including ileus (3 in the radical resection and 2 in the palliative resection groups) and anastomosis (2 cases in each group) was not significantly different (P > 0.05). The cumulative survival rate was significantly lower in the palliative resection group (P < 0.05).
CONCLUSION: Radical gastrectomy with resection of hepatic metastases and hepatoarterial catheter implantation is the recommended surgery for late-stage gastric cancer patients with hepatic metastases.

Entities:  

Keywords:  Cumulative survival curve; Gastric cancer; Hepatic metastases; Palliative gastrectomy; Radical gastrectomy

Mesh:

Substances:

Year:  2015        PMID: 25759546      PMCID: PMC4351228          DOI: 10.3748/wjg.v21.i9.2754

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

1.  Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer.

Authors:  Yoshihiro Sakamoto; Takeshi Sano; Kazuaki Shimada; Minoru Esaki; Makoto Saka; Takeo Fukagawa; Hitoshi Katai; Tomoo Kosuge; Mitsuru Sasako
Journal:  J Surg Oncol       Date:  2007-06-01       Impact factor: 3.454

2.  Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).

Authors:  Nancy E Kemeny; Donna Niedzwiecki; Donna R Hollis; Heinz-Josef Lenz; Robert S Warren; Michelle J Naughton; Jane C Weeks; Elin R Sigurdson; James E Herndon; Chunfeng Zhang; Robert J Mayer
Journal:  J Clin Oncol       Date:  2006-02-27       Impact factor: 44.544

3.  Benefits and limits of hepatic resection for gastric metastases.

Authors:  S Ambiru; M Miyazaki; H Ito; K Nakagawa; H Shimizu; H Yoshidome; Y Shimizu; N Nakajima
Journal:  Am J Surg       Date:  2001-03       Impact factor: 2.565

4.  Long-term survival after surgical resection for liver metastasis from gastric cancer: two case reports.

Authors:  Jong Keun Lim; Joong Bae Ahn; Sung Ha Cheon; Hyun Chang; Jong Yul Jung; Sun Young Rha; Jae Kyung Roh; Sung Hoon Noh; Ho Geun Kim; Hyun Cheol Chung; Hei-Cheul Jeung
Journal:  Cancer Res Treat       Date:  2006-06-30       Impact factor: 4.679

Review 5.  The role of floxuridine in metastatic liver disease.

Authors:  Derek G Power; Nancy E Kemeny
Journal:  Mol Cancer Ther       Date:  2009-04-21       Impact factor: 6.261

6.  Chemotherapy and resection for gastric cancer with synchronous liver metastases.

Authors:  Lei Chen; Ming-Quan Song; Hui-Zhong Lin; Lin-Hua Hao; Xiang-Jun Jiang; Zi-Yu Li; Yu-Xin Chen
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

7.  Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors.

Authors:  Rintaro Koga; Junji Yamamoto; Shigekazu Ohyama; Akio Saiura; Makoto Seki; Yasuyuki Seto; Toshiharu Yamaguchi
Journal:  Jpn J Clin Oncol       Date:  2007-10-10       Impact factor: 3.019

8.  Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection.

Authors:  Ken Shirabe; Mitsuo Shimada; Takashi Matsumata; Hidefumi Higashi; Yohichi Yakeishi; Shigeki Wakiyama; Yasuharu Ikeda; Takuhiro Ezaki; Shingo Fukuzawa; Kenji Takenaka; Keishi Kishikawa; Tetsuo Ikeda; Ken-ichi Taguchi; Yoshihiko Maehara; Keizo Sugimachi
Journal:  Hepatogastroenterology       Date:  2003 Sep-Oct

9.  A case with synchronous multiple liver metastases from gastric carcinoma: postoperative long-term disease-free survival.

Authors:  Masaya Munekage; Takehiro Okabayashi; Norihiro Hokimoto; Takeki Sugimoto; Hiromichi Maeda; Tsutomu Namikawa; Ken Dabanaka; Michiya Kobayashi; Keijiro Araki; Kazuhiro Hanazaki
Journal:  Langenbecks Arch Surg       Date:  2008-11-11       Impact factor: 3.445

10.  Gastric cancer epidemiology in Korea.

Authors:  Aesun Shin; Jeongseon Kim; Sohee Park
Journal:  J Gastric Cancer       Date:  2011-09-29       Impact factor: 3.720

View more
  3 in total

Review 1.  Prognostic and Clinicopathological Value of Rac1 in Cancer Survival: Evidence from a Meta-Analysis.

Authors:  Shu Lou; Penglai Wang; Jianrong Yang; Junqing Ma; Chao Liu; Meng Zhou
Journal:  J Cancer       Date:  2018-06-23       Impact factor: 4.207

2.  Identifying Optimal Surgical Intervention-Based Chemotherapy for Gastric Cancer Patients With Liver Metastases.

Authors:  Min Sun; Hangliang Ding; Zhiqiang Zhu; Shengsheng Wang; Xinsheng Gu; Lingyun Xia; Tian Li
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

3.  Peri-operative Outcomes and Survival Following Palliative Gastrectomy for Gastric Cancer: a Systematic Review and Meta-analysis.

Authors:  Joseph Cowling; Bethany Gorman; Afrah Riaz; James R Bundred; Sivesh K Kamarajah; Richard P T Evans; Pritam Singh; Ewen A Griffiths
Journal:  J Gastrointest Cancer       Date:  2020-09-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.